Risk reduction surgery in non-BRCA carriers–is less more?

被引:0
|
作者
机构
关键词
D O I
10.1038/nrclinonc.2012.243
中图分类号
学科分类号
摘要
引用
收藏
页码:67 / 67
相关论文
共 50 条
  • [21] Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results
    不详
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (10): : 660 - 664
  • [22] Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results
    Pedro Pérez Segura
    Paula Jiménez
    Helena Olivera
    Raquel Andrés Conejero
    Trinidad Caldés
    Miguel de la Hoya
    Jose María Román
    Arancha Moreno
    Javier Puente
    Eduardo Díaz-Rubio
    Clinical and Translational Oncology, 2008, 10
  • [23] Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC)
    Madrigal, Laura Fernandez
    Garces, Maria Yeray Rodriguez
    Ruiz, Francisco Javier Jimenez
    CURRENT PROBLEMS IN CANCER, 2023, 47 (06)
  • [24] Management of non-BRCA breast cancer predisposition
    Robson, M.
    CANCER RESEARCH, 2016, 76
  • [25] Factors influencing risk reduction surgery among BRCA mutation carriers: A qualitative analysis.
    Brandt, Rachael
    Polinsky, Cristina
    Katz, Jessica
    Dhamankar, Minal
    Tucci, Rosemarie
    Sabol, Jennifer L.
    McHugh, Terri
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [26] Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer
    Wood, Marie E.
    McKinnon, Wendy
    Garber, Judy
    BREAST JOURNAL, 2020, 26 (08): : 1528 - 1534
  • [29] Hysterectomy at the time of risk-reducing surgery in BRCA carriers
    Nair, Navya
    Schwartz, Melissa
    Guzzardi, Lisa
    Durlester, Nicki
    Pan, Stephanie
    Overbey, Jessica
    Chuang, Linus
    GYNECOLOGIC ONCOLOGY REPORTS, 2018, 26 : 71 - 74
  • [30] Comparing prognosis for BRCA1, BRCA2 and non-BRCA breast cancer
    Meireles, Pedro Antunes
    Bexiga, Catarina
    Fragoso, Sofia
    Santos, Sidonia
    Duarte, Teresa
    Vaz, Fatima
    CANCER RESEARCH, 2024, 84 (09)